23. The Role of Treatment Setting in the Pharmacotherapy of Bipolar Disorder

  1. Hagop S. Akiskal2 and
  2. Mauricio Tohen3
  1. Jean-Michel Azorin

Published Online: 14 APR 2011

DOI: 10.1002/9780470975114.ch23

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

How to Cite

Azorin, J.-M. (2011) The Role of Treatment Setting in the Pharmacotherapy of Bipolar Disorder, in Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition (eds H. S. Akiskal and M. Tohen), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470975114.ch23

Editor Information

  1. 2

    International Mood Center, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0603, USA

  2. 3

    Department of Psychiatry, Division of Mood and Anxiety Disorders, University of Texas Health Science Centre at San Antonio, 7730 Floyd Curl Drive, San Antonio, TX 78229, USA

Author Information

  1. Department of Psychiatry, Ste Marguerite Hospital, 13274 Marseille Cedex 9, France

Publication History

  1. Published Online: 14 APR 2011
  2. Published Print: 15 APR 2011

ISBN Information

Print ISBN: 9780470747216

Online ISBN: 9780470975114

SEARCH

Keywords:

  • Role of Treatment Setting in the Pharmacotherapy of Bipolar Disorder;
  • “threatening”;
  • “chronic psychotic”;
  • Drug Response and Treatment Setting;
  • “trans-institutionalization”

Summary

This chapter contains sections titled:

  • Implementation of drug treatment according to phase and severity of illness

  • Pretreatment evaluation and monitoring of pharmacotherapy

  • Drug response and treatment setting

  • From efficacy to efficiency of pharmacotherapy in bipolar illness

  • References